SMAD3 and hepatocellular carcinoma: In human hepatocellular carcinoma cell lines (HCC), the HO-1/CO axis conferred resistance to the TGF-β growth inhibitory signal by increasing Smad3 phosphorylation at Thr-179 via the ERK1/2 pathway17.